
Allergy
AGY.LAllergy Therapeutics plc Price (AGY.L)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
3,743,332,000
(458.4104)%Description
Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pet... Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $0.067-8
- Market Cap 333.65M
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Drug Manufacturers - Specialty & Generic
- ceo: Mr. Manuel Llobet
- IPO Date: October, 11, 2004
- Country: GB
- Currency: GBp
- Headquaters: No Data
- Employees: 612
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
